Angiotensin II generation in vivo: Does it involve enzymes other than renin and angiotensin-converting enzyme?

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 13, Issue 2, 2012, Pages 314-316

  Campbell, Duncan J ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CHYMASE; DIPEPTIDYL CARBOXYPEPTIDASE; RENIN;

ARTICLE; ENZYME ACTIVITY; HORMONE SYNTHESIS; HUMAN; NONHUMAN; PROTEIN FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN II; ANIMALS; CHYMASES; HUMANS; PEPTIDYL-DIPEPTIDASE A; RENIN;

EID: 84861871226     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320312447162     Document Type: Article

References (26)

1. Campbell DJ. Circulating and tissue angiotensin systems. J Clin Invest. 1987 ; 79: 1-6 (Pubitemid 17232490)
2. Campbell DJ, Kladis A, Skinner SL, et al. Characterization of angiotensin peptides in plasma of anephric man. J Hypertens. 1991 ; 9: 265-274
3. Campbell DJ. Critical review of prorenin and (pro)renin receptor research. Hypertension. 2008 ; 51: 1259-1264 (Pubitemid 351555933)
4. Danser AHJ, Van Kats JP, Admiraal PJJ, et al. Cardiac renin and angiotensins: Uptake from plasma versus in situ synthesis. Hypertension. 1994 ; 24: 37-48 (Pubitemid 24195402)
5. Campbell DJ, Kladis A, Duncan A-M. Nephrectomy, converting enzyme inhibition and angiotensin peptides. Hypertension. 1993 ; 22: 513-522 (Pubitemid 23292157)
6. Moreno C, Hoffman M, Stodola TJ, et al. Creation and characterization of a renin knockout rat. Hypertension. 2011 ; 57: 614-619
7. Yanai K, Saito T, Kakinuma Y, et al. Renin-dependent cardiovascular functions and renin-independent blood- brain barrier functions revealed by renin-deficient mice. J Biol Chem. 2000 ; 275: 5-8 (Pubitemid 30038945)
8. Gribouval O, Moriniere V, Pawtowski A, et al. Spectrum of mutations in the renin-angiotensin system genes in autosomal recessive renal tubular dysgenesis. Hum Mutat. 2012 ; 33: 316-326
9. Nussberger J, Delabays A, de Gasparo M, et al. Hemodynamic and biochemical consequences of renin inhibition by infusion of CGP 38560A in normal volunteers. Hypertension. 1989 ; 13: 948-953 (Pubitemid 19157995)
10. Nussberger J, Wuerzner G, Jensen C, et al. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril. Hypertension. 2002 ; 39: e1 - e8
11. Alexiou T, Boon WM, Denton DA, et al. Angiotensinogen and angiotensin converting enzyme gene copy number and angiotensin and bradykinin peptide levels in mice. J Hypertens. 2005 ; 23: 945-954 (Pubitemid 40637912)
12. Campbell DJ, Alexiou T, Xiao HD, et al. Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice. Hypertension. 2004 ; 43: 854-859 (Pubitemid 38405600)
13. Campbell DJ, Kladis A, Duncan A-M. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension. 1994 ; 23: 439-449 (Pubitemid 24102039)
14. Campbell DJ, Duncan A-M, Kladis A. Angiotensin converting enzyme inhibition modifies angiotensin, but not kinin peptide levels in human atrial tissue. Hypertension. 1999 ; 34: 171-175 (Pubitemid 29409210)
15. Zeitz CJ, Campbell DJ, Horowitz JD. Myocardial uptake and biochemical and hemodynamic effects of ACE inhibitors in humans. Hypertension. 2003 ; 41: 482-487 (Pubitemid 36314620)
16. Chandrasekharan UM, Sanker S, Glynias MJ, et al. Angiotensin II-forming activity in a reconstructed ancestral chymase. Science. 1996 ; 271: 502-505
17. Li M, Liu K, Michalicek J, et al. Involvement of chymase-mediated angiotensin II generation in blood pressure regulation. J Clin Invest. 2004 ; 114: 112-120 (Pubitemid 39071650)
18. Kunori Y, Muroga Y, Iidaka M, et al. Species differences in angiotensin II generation and degradation by mast cell chymases. J Recept Signal Transduct Res. 2005 ; 25: 35-44 (Pubitemid 40780996)
19. Urata H, Kinoshita A, Misono KS, et al. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem. 1990 ; 265: 22348-22357 (Pubitemid 120014308)
20. Campbell DJ, Xiao H, Fuchs S, et al. Genetic models provide unique insight into angiotensin and bradykinin peptides in the extravascular compartment of the heart in vivo. Clin Exp Pharmacol Physiol. 2009 ; 36: 547-553
21. Pitt B, Poole-Wilson PA, Segal R, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II. Lancet. 2000 ; 355: 1582-1587 (Pubitemid 30240502)
22. Takai S, Jin D, Miyazaki M. Multiple mechanisms for the action of chymase inhibitors. J Pharmacol Sci. 2012 ; 118: 311-316
23. Uehara Y, Urata H, Ideishi M, et al. Chymase inhibition suppresses high-cholesterol diet-induced lipid accumulation in the hamster aorta. Cardiovasc Res. 2002 ; 55: 870-876
24. Dell'Italia LJ, Meng QC, Balcells E, et al. Compartmentalization of angiotensin II generation in the dog heart - Evidence for independent mechanisms in intravascular and interstitial spaces. J Clin Invest. 1997 ; 100: 253-258 (Pubitemid 27349070)
25. Wei CC, Hase N, Inoue Y, et al. Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents. J Clin Invest. 2010 ; 120: 1229-1239
26. Kokkonen JO, Saarinen J, Kovanen PT. Regulation of local angiotensin II formation in the human heart in the presence of interstitial fluid - Inhibition of chymase by protease inhibitors of interstitial fluid and of angiotensin-converting enzyme by Ang-(1-9) formed by heart carboxypeptidase A-like activity. Circulation. 1997 ; 95: 1455-1463 (Pubitemid 27142803)